Bristol-Myers Squibb Signs With High Tower Software For An Advanced Clinical Data Management And Reporting System

High Tower Software's TowerView Clinical Helps Speed the Development of Essential Pharmaceuticals

25-Sep-2001

Bristol-Myers Squibb (NYSE: BMY), one of the world's largest pharmaceutical companies, has signed a contract with High Tower Software™, the world's leading provider of operational business intelligence solutions.

High Tower Software's TowerView Clinical product will provide Bristol-Myers Squibb with a state of the art Clinical Laboratory Reporting System that offers the very latest in technology for managing clinical laboratory data and reports. This new capability represents the first of many being implemented as a part of a major Bristol-Myers Squibb informatics initiative to expand Exploratory Development capabilities.

Through a combination of High Tower's award winning dynamic visualization technology, custom analytics and web-enabled reporting software, High Tower's solution provides clinical laboratory personnel with immediate, flexible and reliable access to trial data from any number of projects in a manner consistent with the very best practices for laboratory reporting. Financial terms of the transaction were not disclosed.

Bristol-Myers Squibb will use High Tower Software's TowerView Clinical to provide and manage hundreds of medical reports from each of dozens of simultaneous clinical trials. The reports are managed through TowerView's patented three-dimensional CyberGrid environment that provides a comprehensive overview of all the data from any trial or protocol. In conjunction with this 3-D environment, TowerView Clinical includes extensive analytics that enable the automatic detection of any data element or trend that requires immediate analysis. TowerView Clinical can transform the way in which pharmaceutical development teams monitor, share and act on critical trial data.

Bristol-Myers Squibb is using TowerView Clinical to capitalize on its consolidated worldwide research and development function by enabling scientists, clinicians, project teams, and managers to undertake powerful monitoring, analysis, query, and reporting of clinical trial data, and to share this information with other development teams within its organization. Bristol-Myers Squibb hopes that the High Tower Software will bring greater efficiency to its research activities, thereby helping to speed the delivery of breakthrough pharmaceutical remedies to patients around the globe.

"Technology has enabled scientists to generate information faster than ever before. Harnessing that information and turning it into shared knowledge, will help our R&D organization achieve its ultimate goal -- bringing drugs to market faster," said George Goldsmith, Informatics Co-leader, Bristol-Myers Squibb.

"Bristol-Myers Squibb joins the growing number of leading-edge organizations that are benefiting from the dynamic monitoring and analysis of key information through the adoption of TowerView as their operational business intelligence platform," said Dr. Ursula Schwuttke, CEO of High Tower Software. "High Tower Software is able to put relevant, accurate, and timely information into the hands of the right people where and when they need it, in a way that is impossible with traditional business intelligence software."

https://www.chemeurope.com/en/news/4917/bristol-myers-squibb-signs-with-high-tower-software-for-an-advanced-clinical-data-management-and-reporting-system.html